Synutra International (Synutra International) Research & Development : $0.0 Mil (TTM As of Dec. 2016)

View and export this data going back to 2004. Start your Free Trial

What is Synutra International Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Synutra International's Research & Development for the three months ended in Dec. 2016 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2016 was $0.0 Mil.

Synutra International Research & Development Historical Data

The historical data trend for Synutra International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synutra International Research & Development Chart

Synutra International Annual Data

Trend

Mar07

Mar08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Research & Development

Get a 7-Day Free Trial

Synutra International Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Synutra International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Synutra International (NAS:SYUT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Synutra International Research & Development Related Terms

Thank you for viewing the detailed overview of Synutra International's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Synutra International (Synutra International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Synutra International Inc (NAS:SYUT) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.synutra.com

Synutra International Inc was formed on October 30, 1998. The Company is engaged in the production, distribution & sales of dairy based nutritional products under Shengyuan or Synutra line of brands in China. Its other nutritional product includes prepared foods, nutritional ingredients & supplements. It is focused on selling powdered formula products for infants and adults, and is also engaged in other nutritional product offerings, such as prepared foods and certain nutritional supplements. It sells the products through an extensive nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. It has three reportable segments; nutritional food, nutritional supplement and other business. The Nutritional Food segment includes the sale of powdered infant and adult formula products, with brands including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the Huiliduo brand; Nutritional Supplement: includes the production and sale of nutritional supplements such as chondroitin sulfate to third parties, and microencapsulated Docosahexanoic Acid ("DHA") and Arachidonic Acid ("ARA") to the nutritional food segment for use in powdered formula production; and Other Business includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers, providing genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women. Its business requires certain key raw materials, such as milk powder and whey powder. The Company competes with both multinational and domestic infant formula producers.

Executives

Warburg Pincus & Co.	10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Warburg Pincus Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Partners Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Joseph P. Landy	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Charles R Kaye	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Private Equity Ix, L.p.	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Ix Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
David Hui Li	director	C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017

Synutra International (Synutra International) Headlines

No Headlines